Recently, in vivo studies have shown that colon cancer metastasis results from an alteration in the balance between the angiogenesis inhibitor thrombospondin-2 and the angiogenic growth factor VEGF189 (Tokunaga et al, 1998). The gene discussed is THBS2; the disease is malignant colon neoplasm.